Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
112 hedge funds and large institutions have $690M invested in Intersect ENT, Inc in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 36 reducing their positions, and 34 closing their positions.
266% more call options, than puts
Call options by funds: $15.1M | Put options by funds: $4.13M
47% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 36
18% less funds holding
Funds holding: 136 → 112 (-24)
26% less capital invested
Capital invested by funds: $927M → $690M (-$237M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
62% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$66M |
| 2 |
DM
Deerfield Management
New York
|
+$29.7M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$15.1M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$15.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$29.7M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$26M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$18.9M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$17M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.1M |
XENT Hedge Fund Activity: Q2 2019 in Review
112 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2019, worth a combined $690M — down 26% from $927M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of XENT and 13 opened new positions — a net loss of 21 holders — while 36 trimmed existing stakes and 53 added.
The largest buyer was Point72 Asset Management, adding an estimated $66M. The largest seller was AllianceBernstein, cutting an estimated $29.7M.
- 112 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2019, down from 136 in Q1 2019.
- Funds reported $690M of Intersect ENT, Inc stock for Q2 2019, down 26% quarter-over-quarter.
- 13 funds opened new Intersect ENT, Inc positions in Q2 2019 and 34 closed out, a net change of -21 holders.
- The largest Intersect ENT, Inc buyer in Q2 2019 was Point72 Asset Management, an estimated $66M added.
- The largest Intersect ENT, Inc seller in Q2 2019 was AllianceBernstein, an estimated $29.7M sold.
Based on aggregated 13F filings for Q2 2019.